vs
Side-by-side financial comparison of Canaan Inc. (CAN) and MDxHealth SA (MDXH). Click either name above to swap in a different company.
Canaan Inc. is the larger business by last-quarter revenue ($20.8M vs $19.8M, roughly 1.0× MDxHealth SA).
Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.
MDxHealth SA is a global molecular diagnostics company specializing in non-invasive precision oncology tests focused primarily on urological cancers including prostate and bladder cancer. It operates across key markets in North America and Europe, providing clinicians with actionable diagnostic insights to guide personalized treatment decisions, reduce unnecessary invasive procedures, and improve patient care outcomes.
CAN vs MDXH — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.8M | $19.8M |
| Net Profit | $-3.8M | — |
| Gross Margin | 99.9% | 60.8% |
| Operating Margin | -15.9% | -33.3% |
| Net Margin | -18.4% | — |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.8M | — | ||
| Q3 25 | $13.8M | — | ||
| Q2 25 | $11.4M | — | ||
| Q1 25 | — | $19.8M | ||
| Q3 24 | $10.2M | — | ||
| Q2 24 | $4.8M | — | ||
| Q1 24 | — | $14.7M |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-1.5M | — | ||
| Q2 25 | $-11.9M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-10.4M | — | ||
| Q2 24 | $-5.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | 99.9% | — | ||
| Q3 25 | 99.9% | — | ||
| Q2 25 | 99.9% | — | ||
| Q1 25 | — | 60.8% | ||
| Q3 24 | 99.9% | — | ||
| Q2 24 | 99.8% | — | ||
| Q1 24 | — | 59.3% |
| Q4 25 | -15.9% | — | ||
| Q3 25 | -27.0% | — | ||
| Q2 25 | -45.5% | — | ||
| Q1 25 | — | -33.3% | ||
| Q3 24 | -77.2% | — | ||
| Q2 24 | -193.9% | — | ||
| Q1 24 | — | -59.3% |
| Q4 25 | -18.4% | — | ||
| Q3 25 | -11.0% | — | ||
| Q2 25 | -104.4% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | -102.7% | — | ||
| Q2 24 | -112.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $-0.25 | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $6.2M | — |
| Stockholders' EquityBook value | $52.4M | — |
| Total Assets | $92.5M | — |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $52.4M | — | ||
| Q3 25 | $44.7M | — | ||
| Q2 25 | $33.8M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $43.6M | — | ||
| Q2 24 | $56.8M | — | ||
| Q1 24 | — | — |
| Q4 25 | $92.5M | — | ||
| Q3 25 | $81.7M | — | ||
| Q2 25 | $78.0M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $69.3M | — | ||
| Q2 24 | $73.7M | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
